BSP Spring Meeting 2026 in Collaboration with Elsevier
Schedule : Back to Bronwyn Neufeld

Assessment of the prevalence of male genital schistosomiasis across three communities in Zambia by different diagnostic tests: the SchistoM pilot study

Wed8 Apr09:40am(15 mins)
Where:
JMS Breakout Room (Room 745)
Speaker:

Authors

B Neufeld7; S España-Cueto8; I Mshanga9; R Ndubani9; F Allan3; L van Lieshout5; B Webster2; M Cheeba9; L Cunningham1; T Marlais4; S Hamano6; SA Kayuni10; JR Stothard1; M Simwinga9; K Shanaube9; A Bustinduy41 Liverpool School of Tropical Medicine, UK;  2 Natural History Museum, UK;  3 University of Glasgow , UK;  4 London School of Hygiene and Tropical Medicine, UK;  5 Leiden University Medical Centre, Netherlands;  6 Nagasaki University, Japan;  7 London School of Hygiene & Tropical Medicine, UK;  8 Fundació Lluita contra les Infeccions, Spain;  9 Zambart, Zambia;  10 Malawi-Liverpool-Wellcome Programme, Kamuzu University of Health Sciences, Malawi

Discussion

Background: Male genital schistosomiasis (MGS) is a neglected tropical disease which results from the deposition of Schistosoma haematobium eggs within the male genital tract and reproductive organs. MGS is underreported partly due to diagnostic challenges and a lack of awareness within health systems. Prior to this study, no studies on male genital schistosomiasis had been conducted in Zambia. The aim of this pilot study was to assess the prevalence of MGS in male household members of women recruited to an ongoing longitudinal female genital schistosomiasis cohort study (Zipime Weka Schista!) across three sites of varying endemicity in Zambia, and evaluate the performance of two different diagnostic tests on semen (egg microscopy and Schistosoma ITS-2 qPCR). 

 

Methods: A total of 156 men were recruited into the study after community sensitization and obtaining written informed consent. Of these, 155 (99.4%) completed a symptom questionnaire, 156 (100%) provided urine, and 47/156 (30.1%) provided semen. Microscopy was performed on semen and urine for the detection of Schistosoma haematobium eggs, and Schistosoma ITS2 qPCR was performed on DNA extracted from semen. Due to the lack of a suitable diagnostic reference standard the performance of each diagnostic test for MGS (semen microscopy, ITS2-qPCR) was assessed using a composite reference standard (CRS), defined as being positive by either test. 

 

Results: The overall prevalence of MGS by either diagnostic across all sites was 12.8% (6.4% [3/47] by semen microscopy and 12.8% [6/47] by semen qPCR). Overall prevalence was highest in Site 3 (27.3%, 3/11), compared to Site 1 (9.1%, 2/22) and Site 2 (7.1%, 1/14). Against the CRS, the sensitivity of semen microscopy was 50.0% (95% CI: 11.8-88.2) and the sensitivity of semen qPCR was 100.0% (95% CI: 54.1-100.0).

 

Conclusions: This pilot study presents the first data on MGS in Zambia and is the first evaluation of MGS diagnostics using a composite reference standard. We show that MGS is prevalent in Zambia and that qPCR on semen is a highly sensitive diagnostic method compared to microscopy. Further optimization of diagnostic tools for MGS, particularly for use in resource-constrained settings, is needed to facilitate enhanced case detection.

supporting document

Hosted By

British Society for Parasitology (BSP)

We are science based Charitable Incorporated Organisation

Get the App

Get this event information on your mobile by
going to the Apple or Google Store and search for 'myEventflo'
iPhone App
Android App
www.myeventflo.com/2554